000 | 01823 a2200505 4500 | ||
---|---|---|---|
005 | 20250515145401.0 | ||
264 | 0 | _c20090112 | |
008 | 200901s 0 0 eng d | ||
022 | _a0174-304X | ||
024 | 7 |
_a10.1055/s-0028-1085466 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPranzatelli, M R | |
245 | 0 | 0 |
_aNeurometabolic effects of ACTH on free amino compounds in opsoclonus-myoclonus syndrome. _h[electronic resource] |
260 |
_bNeuropediatrics _cJun 2008 |
||
300 |
_a164-71 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdrenocorticotropic Hormone _xpharmacology |
650 | 0 | 4 |
_aAlanine _xcerebrospinal fluid |
650 | 0 | 4 |
_aAmino Acids _xcerebrospinal fluid |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aChromatography, Gas _xmethods |
650 | 0 | 4 |
_aCorticosterone _xpharmacology |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlutamine _xcerebrospinal fluid |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunotherapy _xmethods |
650 | 0 | 4 |
_aLysine _xcerebrospinal fluid |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMass Spectrometry _xmethods |
650 | 0 | 4 |
_aOpsoclonus-Myoclonus Syndrome _xcerebrospinal fluid |
650 | 0 | 4 |
_aOrnithine _xcerebrospinal fluid |
650 | 0 | 4 |
_aPhenylalanine _xcerebrospinal fluid |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 |
_aTaurine _xcerebrospinal fluid |
650 | 0 | 4 |
_aTyrosine _xcerebrospinal fluid |
700 | 1 | _aTate, E D | |
700 | 1 | _aCrowley, J M | |
700 | 1 | _aToennies, B | |
700 | 1 | _aCreer, M | |
773 | 0 |
_tNeuropediatrics _gvol. 39 _gno. 3 _gp. 164-71 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1055/s-0028-1085466 _zAvailable from publisher's website |
999 |
_c18452135 _d18452135 |